BIOREM Inc.
BRM.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.61M | 246.20K | 255.20K | 1.71M | 375.10K |
| Total Depreciation and Amortization | 135.40K | 54.70K | 54.60K | 144.70K | 36.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 617.80K | 131.40K | 129.60K | 447.90K | 164.90K |
| Change in Net Operating Assets | -91.50K | -1.82M | 2.66M | -2.27M | 1.34M |
| Cash from Operations | 2.27M | -1.39M | 3.10M | 28.20K | 1.91M |
| Capital Expenditure | 0.00 | -2.70K | -269.30K | 88.70K | -179.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -2.70K | -269.30K | 88.70K | -179.60K |
| Total Debt Issued | -- | -- | -- | -- | -365.00K |
| Total Debt Repaid | -201.70K | -170.00K | -227.70K | -97.60K | -963.00K |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -147.90K | -124.30K | -168.90K | -71.70K | -990.10K |
| Foreign Exchange rate Adjustments | 350.10K | 53.60K | 17.20K | -112.40K | -147.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.47M | -1.46M | 2.68M | -67.10K | 594.70K |
